Acute myeloid leukaemia (AML) is a heterogenous disease. Prognosis of AML is influenced
both by patient‐specific as well as disease‐specific factors. Age is the most prominent …

Acute myeloid leukemia is an aggressive myeloid neoplasm characterized by≥ 20%
myeloblasts in the blood or bone marrow. Current treatment strategies for acute myeloid …

The prognosis between subgroups of patients with acute myeloid leukaemia (AML) may
range considerably. Haematological, genetic and clinical analysis has provided possibilities …

Acute myeloid leukemia (AML) is a heterogenous disorder that results from a block in the
differentiation of hematopoietic progenitor cells along with uncontrolled proliferation. In …

Prognostic factors in acute myeloid leukemia : Current Opinion in Hematology Prognostic
factors in acute myeloid leukemia : Current Opinion in Hematology Log in or Register Subscribe …

The yearly incidence of acute myeloblastic leukaemia (AML) in European adults is five to
eight cases per 100 000 individuals with a steep increase in the population aged over 70 …

Recommendations for classification in AML have been published by the European
Leukemia Network (ELN). We evaluated these recommendations within an independent …

The prognosis for patients with acute myelogenous leukemia (AML) is dependent on age,
karyotype, and the genetics of the neoplastic cell. The molecular markers with prognostic …

The karyotype is so far the most important prognostic parameter in acute myeloid leukemia
(AML). Molecular mutations have been analyzed to subdivide AML with normal karyotype …

Pretreatment clinical features and prognosis of patients with acute myeloid leukemia (AML)
are strongly influenced by acquired genetic alterations in leukemic cells, which include …